Gaithersburg, MD, United States of America

Mili Gu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The Secretary of State for Health. Active years: 2014.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mili Gu: Innovator in Immunogenic Peptide Technology

Introduction

Mili Gu is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of immunology through her innovative work on chemically modified peptides. Her research focuses on enhancing the immunogenicity of peptides, which is crucial for vaccine development.

Latest Patents

Mili Gu holds a patent for "Chemically modified peptides with improved immunogenicity." This invention provides processes for improving the ability of a peptide to stimulate an immune response by exposing the peptide to a chemical modifying agent. The patent also includes compositions comprising an antigenic peptide that has been treated with a chemical modifying agent to enhance its ability to stimulate an immune response. Furthermore, it outlines methods for stimulating an immune response in a mammal by administering an effective amount of a vaccine.

Career Highlights

Mili Gu is currently employed at the Secretary of State for Health, where she continues to advance her research in immunology. Her work is instrumental in developing new strategies for vaccine enhancement, which can lead to better health outcomes.

Collaborations

Mili collaborates with notable colleagues, including Xiaomi Tong and Clifford Charles Shone. These partnerships foster a dynamic research environment that encourages innovation and the sharing of ideas.

Conclusion

Mili Gu's contributions to the field of immunology through her patented work on chemically modified peptides highlight her role as a leading inventor. Her ongoing research promises to have a lasting impact on vaccine development and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…